The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Inhibition of furin-mediated cleavage activation of HIV-1 glycoprotein gpl60
Abstract
The envelope glycoprotein of human immunodeficiency virus (HIV) initiates infection by mediating fusion of the viral envelope with the cell membrane. Fusion activity requires proteolytic cleavage of the gp160 protein into gp120 and gp41 at a site containing several arginine and lysine residues. Activation at basic cleavage sites is observed with many membrane proteins of cellular and viral origin. We have recently found that the enzyme activating the haemagglutinin of fowl plague virus (FPV), an avian influenza virus, is furin. Furin, a subtilisin-like eukaryotic endoprotease, has a substrate specificity for the consensus amino-acid sequence Arg-X-Lys/Arg-Arg at the cleavage site. We show here that the glycoprotein of HIV-1, which has the same protease recognition motif as the FPV haemagglutinin, is also activated by furin.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In case of HIV-1, the Env glycoproteins precursor, gp160, is cleaved in the Golgi by cellular furin or furin-like PRs into: (i) a mature surface glycoprotein gp120 and (ii) the transmembrane glycoprotein gp41”
From Beyond reverse transcription: molecular mechanisms and emerging paradigms in retroviral replication (2026) · cites this paper as Hallenberger et al. 1992
Citations
Cites
The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus
Dalgleish, A. G., Beverley, P. C. L., Clapham, P. R., Crawford, D., Greaves, M. F., & Weiss, R. A. (1984) · Nature · doi:10.1038/312763a0 · Cited by 3,539
Human Retroviruses and Aids - 1999
KUIKEN, C. L., & Foley, B. T. (1999) · doi:10.2172/1186019 · Cited by 952
Infection of HTLV-III/LAV in HTLV-I-Carrying Cells MT-2 and MT-4 and Application in a Plaque Assay
Harada, S., Koyanagi, Y., & Yamamoto, N. (1985) · Science · doi:10.1126/science.2992081 · Cited by 857
Stieneke-Gröber, A., Vey, M., Angliker, H., Shaw, E., Thomas, G., Roberts, C. R., Klenk, H., & Garten, W. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05305.x · Cited by 643
Self-citationEndoproteolytic cleavage of gp160 is required for the activation of human immunodeficiency virus
McCune, J. M., Rabin, L. B., Feinberg, M. B., Lieberman, M., Kosek, J. C., Reyes, G. R., & Weissman, I. L. (1988) · Cell · doi:10.1016/0092-8674(88)90487-4 · Cited by 610
Hosaka, M., Nagahama, M., Kim, W. S., Watanabe, T., Hatsuzawa, K., Ikemizu, J., Murakami, K., & Nakayama, K. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)98867-8 · Cited by 591
Willey, R. L., Bonifacino, J. S., Potts, B. J., Martin, M. A., & Klausner, R. D. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.24.9580 · Cited by 428
Human fur gene encodes a yeast KEX2-like endoprotease that cleaves pro-beta-NGF in vivo.
Bresnahan, P. A., Leduc, R., Thomas, L., Thorner, J. W., Gibson, H. L., Brake, A. J., Barr, P. J., & Thomas, G. (1990) · The Journal of Cell Biology · doi:10.1083/jcb.111.6.2851 · Cited by 383
Oligomeric structure of the human immunodeficiency virus type 1 envelope glycoprotein.
Earl, P. L., Doms, R. W., & Moss, B. A. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.2.648 · Cited by 365
Wise, R. J., Barr, P. J., WONG, P. A., Kiefer, M. C., Brake, A. J., & Kaufman, R. J. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.23.9378 · Cited by 298
Flagged first, then by citations
Cited by
Sorted by citations
Items 301–400 of 586
Integrins αvβ5 and αvβ6 Mediate IL-4–induced Collective Migration in Human Airway Epithelial Cells
Lee, S., Ahn, J.-S., Lee, S. G., Lee, H., Choi, A. M. K., & Yoon, J. (2018) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2018-0081oc · Cited by 24
Influence of the Small Leader Exons 2 and 3 on Human Immunodeficiency Virus Type 1 Gene Expression
Krummheuer, J., Lenz, C., Kammler, S., Scheid, A., & Schaal, H. (2001) · Virology · doi:10.1006/viro.2001.0974 · Cited by 24
Effects of calcium ions on proteolytic processing of HIV‐1 gp160 precursor and on cell fusion
Moulard, M., Montagnier, L., & Bahraoui, E. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)80284-x · Cited by 24
Rosengarten, J. F., Schatz, S., Wolf, T., Barbe, S., & Stitz, J. (2022) · Virology · doi:10.1016/j.virol.2022.01.008 · Cited by 23
Human brain organoids to explore SARS‐CoV‐2‐induced effects on the central nervous system
Ostermann, P. N., & Schaal, H. (2023) · Reviews in Medical Virology · doi:10.1002/rmv.2430 · Cited by 23
HIV-1 Envelope Glycan Moieties Modulate HIV-1 Transmission
Shen, R., Raška, M., Bimczok, D., Novák, J., & Smith, P. D. (2014) · Journal of Virology · doi:10.1128/jvi.02164-14 · Cited by 25
Ryman, K. D., Klimstra, W. B., & Johnston, R. E. (2004) · Virology · doi:10.1016/j.virol.2004.01.003 · Cited by 23
The disulfide loop of gp41 is critical to the furin recognition site of HIV gp160
Sen, J., Jacobs, A., Jiang, H., Rong, L., & Caffrey, M. S. (2007) · Protein Science · doi:10.1110/ps.072771407 · Cited by 23
Solution structure of the HIV gp120 C5 Domain
Guilhaudis, L., Jacobs, A., & Caffrey, M. S. (2002) · European Journal of Biochemistry · doi:10.1046/j.1432-1033.2002.03187.x · Cited by 23
Bontemps, Y., Scamuffa, N., Calvo, F. M., & Khatib, A. (2006) · Medicinal Research Reviews · doi:10.1002/med.20072 · Cited by 23
Entry of Animal Viruses into Cells
Marsh, M., & Pelchen–Matthews, A. (1993) · Reviews in Medical Virology · doi:10.1002/rmv.1980030307 · Cited by 23
Tilak, A., Nelsen, S., Kim, H.-S., Donley, N., McKnite, A. M., Lee, H., & Christian, J. L. (2014) · Development · doi:10.1242/dev.110130 · Cited by 22
Zarkik, S., Decroly, É., Wattiez, R., Seidah, N. G., Burny, A., & Ruysschaert, J. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)00275-5 · Cited by 22
Effect of alpha-1 antitrypsin Portland variant (α1-PDX) on HIV-1 replication
Bahbouhi, B., Bendjennat, M., Guétard, D., Seidah, N. G., & Bahraoui, E. (2000) · Biochemical Journal · doi:10.1042/0264-6021:3520091 · Cited by 22
Viral and host factors regulating HIV-1 envelope protein trafficking and particle incorporation
Anokhin, B., & Spearman, P. (2022) · Viruses · doi:10.3390/v14081729 · Cited by 21
Sakaguchi, T., Fujii, Y., Kiyotani, K., & Yoshida, T. (1994) · Journal of General Virology · doi:10.1099/0022-1317-75-10-2821 · Cited by 21
Jin, Y., Churchill, N. D., & Michalak, T. I. (1996) · Journal of General Virology · doi:10.1099/0022-1317-77-8-1837 · Cited by 21
Impact of Protein Glycosylation on the Design of Viral Vaccines.
Schön, K., Lepenies, B., & Goyette-Desjardins, G. (2020) · Advances in Biochemical Engineering/Biotechnology · doi:10.1007/10_2020_132 · Cited by 19
The Path to Therapeutic Furin Inhibitors: From Yeast Pheromones to SARS-CoV-2
Thomas, G., Couture, F., & Kwiatkowska, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23073435 · Cited by 21
Recent Advances in the Molecular and Cellular Mechanisms of gp120-Mediated Neurotoxicity
Avdoshina, V., & Mocchetti, I. (2022) · Cells · doi:10.3390/cells11101599 · Cited by 21
Small Molecule Inhibitors Targeting Chikungunya Virus
Haese, N. N., Powers, J. M., & Streblow, D. N. (2020) · Current topics in microbiology and immunology · doi:10.1007/82_2020_195 · Cited by 21
Cordelier, P., & Strayer, D. S. (2003) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/s0925-4439(03)00084-x · Cited by 20
Arachchige, S. P., Henke, W., Pramanik, A. S., Kalamvoki, M., & Stephens, E. B. (2017) · Journal of Virology · doi:10.1128/jvi.01476-17 · Cited by 18
Samal, S., Das, S., Boliar, S., Qureshi, H., Shrivastava, T., Kumar, N., Goswami, S., Bansal, M., & Chakrabarti, B. K. (2018) · Retrovirology · doi:10.1186/s12977-018-0431-4 · Cited by 19
Computer-Aided Approaches for Targeting HIVgp41
Allen, W. J., & Rizzo, R. C. (2012) · Biology · doi:10.3390/biology1020311 · Cited by 19
Kappert, K., Meýborg, H., Baumann, B., Furundzija, V., Kaufmann, J., Graf, K., Stibenz, D., Fleck, E., & Stawowy, P. (2009) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2009.01.004 · Cited by 19
Influences on hepatitis B virus replication by a naturally occurring mutation in the core gene
Sugiyama, M., Tanaka, Y., Kurbanov, F., Nakayama, N., Mochida, S., & Mizokami, M. (2007) · Virology · doi:10.1016/j.virol.2007.04.004 · Cited by 19
The extracellular processing of HIV‐1 envelope glycoprotein gp160 by human plasmin
Okumura, Y., Yano, M., Murakami, M., Mori, S., Towatari, T., & Kido, H. (1999) · FEBS Letters · doi:10.1016/s0014-5793(98)01612-3 · Cited by 19
Wang, M., Tan, Y., Yin, F., Dèng, F., Vlak, J. M., Hú, Z., & Wáng, H. (2008) · Journal of General Virology · doi:10.1099/vir.0.83466-0 · Cited by 19
Wouters, S., Decroly, É., Vandenbranden, M., Schober, D., Fuchs, R., Morel, V., Leruth, M., Seidah, N. G., Courtoy, P. J., & Ruysschaert, J. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)00938-2 · Cited by 19
Coto, E., Albaiceta, G. M., Amado‐Rodríguez, L., Clemente, M. M. G., Cuesta‐Llavona, E., Vázquez‐Coto, D., Alonso, B., Iglesias, S., Melón, S., Álvarez‐Argüelles, M. E., et al. (2022) · Journal of Medical Virology · doi:10.1002/jmv.27748 · Cited by 18
HIV ‐1 Entry Inhibitors: A Review of Experimental and Computational Studies
Mostashari-Rad, T., Saghaie, L., & Fassihi, A. (2018) · Chemistry & Biodiversity · doi:10.1002/cbdv.201800159 · Cited by 18
Fernandez, M. V., Hoffman, H. K., Pezeshkian, N., Tedbury, P. R., van Engelenburg, S. B., & Freed, E. O. (2020) · Journal of Virology · doi:10.1128/jvi.01334-20 · Cited by 16
Craft, W. W., & Dutch, R. (2005) · Virology · doi:10.1016/j.virol.2005.07.004 · Cited by 18
Sjöberg, M., Wallin, M., Lindqvist, B., & Garoff, H. (2006) · Journal of Virology · doi:10.1128/jvi.01851-05 · Cited by 18
Interfering with Host Proteases in SARS-CoV-2 Entry as a Promising Therapeutic Strategy
Müller, P., Maus, H., Hammerschmidt, S. J., Knaff, P. M., Mailänder, V., Schirmeister, T., & Kersten, C. (2021) · Current Medicinal Chemistry · doi:10.2174/0929867328666210526111318 · Cited by 17
Involvement of Envelope-Glycoprotein Glycans in HIV-1 Biology and Infection
Raška, M., & Novák, J. (2010) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-010-0072-3 · Cited by 17
Kappert, K., Meýborg, H., Fritzsche, J., Urban, D., Krüger, J., Wellnhofer, E., Kintscher, U., Fleck, E., & Stawowy, P. (2013) · PLoS ONE · doi:10.1371/journal.pone.0070542 · Cited by 19
Tagliamonte, M., Tornesello, M. L., Buonaguro, L., & Buonaguro, L. (2011) · Journal of Translational Medicine · doi:10.1186/1479-5876-9-s1-s1 · Cited by 17
Functional contributions of carbohydrate on AIDS virus glycoprotein.
Stansell, E., & Desrosiers, R. C. (2010) · PubMed Central · Cited by 17
HIV life cycle and genetic approaches
Ratner, L. (1993) · Perspectives in Drug Discovery and Design · doi:10.1007/bf02171653 · Cited by 17
Diederich, S., Dietzel, E., & Maisner, A. (2009) · Virus Research · doi:10.1016/j.virusres.2009.07.020 · Cited by 16
Heusinger, E., Deppe, K., Sette, P., Krapp, C., Kmieć, D., Kluge, S. F., Marx, P. A., Apetrei, C., Kirchhoff, F., & Sauter, D. (2018) · Journal of Virology · doi:10.1128/jvi.00276-18 · Cited by 17
Planas, D., Fert, A., Zhang, Y., Goulet, J.-P., Richard, J., Finzi, A., Ruiz, M. J., Marchand, L. R., Chatterjee, D., Chen, H., et al. (2020) · Pathogens and Immunity · doi:10.20411/pai.v5i1.348 · Cited by 17
PTSD as an Endothelial Disease: Insights From COVID-19
Sfera, A., Osorio, C. P., Rahman, L., del Campo, C. M. Z.-M., Maldonado, J. C., Jafri, N., Cummings, M. A., Maurer, S., & Kozlakidis, Z. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.770387 · Cited by 16
Changes in the hemagglutinin gene of the neurovirulent influenza virus strain A/NWS/33
Ward, A. C., & de Koning‐Ward, T. F. (1995) · Virus Genes · doi:10.1007/bf01702599 · Cited by 16
PACS1 is an HIV-1 cofactor that functions in Rev-mediated nuclear export of viral RNA
Liu, H., Hu, P.-W., Budhiraja, S., Misra, A., Couturier, J. P., Lloyd, R. E., Lewis, D. E., Kimata, J. T., & Rice, A. P. (2019) · Virology · doi:10.1016/j.virol.2019.10.004 · Cited by 14
Bourinbaiar, A. S., & Lee‐Huang, S. (1995) · Contraception · doi:10.1016/0010-7824(95)00094-q · Cited by 16
Integrin cleavage regulates bidirectional signalling in vascular smooth muscle cells
Kappert, K., Furundzija, V., Fritzsche, J., Margeta, C., Krüger, J., Meýborg, H., Fleck, E., & Stawowy, P. (2010) · Thrombosis and Haemostasis · doi:10.1160/th09-07-0478 · Cited by 16
Ito, J., Baba, T., Kawasaki, J., & Nishigaki, K. (2015) · Journal of Virology · doi:10.1128/jvi.01904-15 · Cited by 14
An Efficiently Cleaved HIV-1 Clade C Env Selectively Binds to Neutralizing Antibodies
Boliar, S., Das, S., Bansal, M., Shukla, B. N., Patil, S. A., Shrivastava, T., Samal, S., Goswami, S., King, C. R., Bhattacharya, J., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0122443 · Cited by 15
Furin as proprotein convertase and its role in normal and pathological biological processes
Solovyeva, N. I., Gureeva, T. A., Timoshenko, O. S., Moskvitina, T. A., & Kugaevskaya, E. V. (2016) · Biomeditsinskaya Khimiya · doi:10.18097/pbmc20166206609 · Cited by 15
Sox9-dependent transcriptional regulation of the proprotein convertase furin
Guimont, P., Grondin, F., & Dubois, C. M. (2007) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00349.2006 · Cited by 15
Endo/exo-proteolysis in neoplastic progression and metastasis
Khatib, A., Bassi, D. E., Siegfried, G., Klein–Szanto, A. J., & Ouafik, L. (2005) · Journal of Molecular Medicine · doi:10.1007/s00109-005-0692-y · Cited by 15
The Role of CD4 and its Downmodulation in Establishment and Maintenance of HIV‐1 Infection
Bour, S., Geleziunas, R., & Wainberg, M. (1994) · Immunological Reviews · doi:10.1111/j.1600-065x.1994.tb00869.x · Cited by 14
Blair, W. S., Cao, J. Q., Jackson, L., Jiménez, J., Peng, Q., Wu, H., Isaacson, J., Butler, S. L., Chu, A., Graham, J. P., et al. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00643-07 · Cited by 14
HIV-Proteins-Associated CNS Neurotoxicity, Their Mediators, and Alternative Treatments
Saro, A., Gao, Z., Kambey, P. A., Pielnaa, P., Marcellin, D. F. H., Luo, A., Zheng, R., Huang, Z., Liao, L., Zhao, M., et al. (2021) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-021-01151-x · Cited by 14
The Triple Threat of HIV-1 Protease Inhibitors
Potempa, M., Lee, S.-K., Wolfenden, R. V., & Swanstrom, R. I. (2015) · Current topics in microbiology and immunology · doi:10.1007/82_2015_438 · Cited by 15
Sulfono-γ-AA modified peptides that inhibit HIV-1 fusion
Bolarinwa, O., Zhang, M., Mulry, E., Lu, M., & Cai, J. (2018) · Organic & Biomolecular Chemistry · doi:10.1039/c8ob02159g · Cited by 13
McCaul, N., Quandte, M., Bontjer, I., van Zadelhoff, G., Land, A., Crooks, E. T., Binley, J. Μ., Sanders, R. W., & Braakman, I. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109646 · Cited by 14
Iminosugar glycosylation inhibitors as anti-HIV agents
Jacob, G. S., & Bryant, M. L. (1993) · Perspectives in Drug Discovery and Design · doi:10.1007/bf02171663 · Cited by 14
Marcon, L., & Sodroski, J. (1994) · Journal of Virology · doi:10.1128/jvi.68.3.1977-1982.1994 · Cited by 14
Alternate pathways of secretion of simian immunodeficiency virus envelope glycoproteins
Spies, C. P., & Compans, R. W. (1993) · Journal of Virology · doi:10.1128/jvi.67.11.6535-6541.1993 · Cited by 14
HIV-1 infection of human placental villous tissue in vitro
Polliotti, B., Sheikh, A. U., Subbarao, S., Keesling, S., Lee, G. R., Caba, J., Panigel, M., Reichman, R. C., Nahmias, A. J., & Miller, R. K. (1998) · Placenta · doi:10.1016/s0143-4004(98)80044-1 · Cited by 13
Zhou, R., Zhang, S., Nguyen, H. T., Ding, H., Gaffney, A., Kappes, J. C., Smith, A. B., & Sodroski, J. (2023) · Journal of Virology · doi:10.1128/jvi.00327-23 · Cited by 12
Lu, W., Chen, S., Yu, J., Behrens, R. T., Wiggins, J., Sherer, N. M., Liu, S., Xiong, Y., Xiang, S.-H., & Wu, L. J. (2019) · Journal of Virology · doi:10.1128/jvi.02128-18 · Cited by 12
SARS-CoV-2 Portrayed against HIV: Contrary Viral Strategies in Similar Disguise
Duerr, R., Crosse, K. M., Valero-Jimenez, A. M., & Dittmann, M. (2021) · Microorganisms · doi:10.3390/microorganisms9071389 · Cited by 12
Wang, L., Sandmeyer, A., Hübner, W., Li, H., Huser, T. R., & Chen, B. K. (2021) · Viruses · doi:10.3390/v14010038 · Cited by 12
Predicting proteolytic sites in extracellular proteins: only halfway there
Kliger, Y., Gofer, E., Wool, A., Toporik, A., Apatoff, A., & Olshansky, M. (2008) · Bioinformatics · doi:10.1093/bioinformatics/btn084 · Cited by 12
Yang, C., Yang, Q., & Compans, R. W. (2000) · Journal of Virology · doi:10.1128/jvi.74.13.6217-6222.2000 · Cited by 12
Mesonero, J. E., Gloor, S. M., & Semenza, G. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.45.29430 · Cited by 12
José, E. S., Muñoz‐Fernández, M. Á., & Alarcón, B. (1998) · Human Gene Therapy · doi:10.1089/hum.1998.9.9-1345 · Cited by 12
Dias, J., Cattin, A., Bendoumou, M., Dutilleul, A., Lodge, R., Goulet, J.-P., Fert, A., Marchand, L. R., Salinas, T. R. W., Yoka, C. D. N., et al. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.114414 · Cited by 12
Comprehensive Insights into the Molecular Basis of HIV Glycoproteins
Elalouf, A., Maoz, H., & Yaniv‐Rosenfeld, A. (2024) · Applied Sciences · doi:10.3390/app14188271 · Cited by 12
HIV-1 Hijacking of Host ATPases and GTPases That Control Protein Trafficking
Tavares, L., Januário, Y. C., & daSilva, L. L. P. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.622610 · Cited by 12
Cendron, L., Rothenberger, S., Cassari, L., Dettin, M., & Pasquato, A. (2022) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2022.10.001 · Cited by 12
Targeting furin, a cellular proprotein convertase, for COVID-19 prevention and therapeutics
Jiang, X., Li, D., Maghsoudloo, M., Zhang, X., Ma, W., & Fu, J. (2024) · Drug Discovery Today · doi:10.1016/j.drudis.2024.104026 · Cited by 11
Stabilization of TM Trimer Interactions during Activation of Moloney Murine Leukemia Virus Env
Sjöberg, M., Lindqvist, B., & Garoff, H. (2007) · Journal of Virology · doi:10.1128/jvi.01931-07 · Cited by 11
Salamango, D. J., & Johnson, M. C. (2015) · Journal of Virology · doi:10.1128/jvi.01901-15 · Cited by 11
Keyvani, H., Ahmadi, N., Ranjbar, M. M., Kachooei, S. A., Ghorban, K., & Dadmanesh, M. (2016) · Archives of Clinical Infectious Diseases · doi:10.5812/archcid.36270 · Cited by 10
Lee, S., Choi, I.-S., Kim, H. J., Yang, E. J., Min, H. J., & Yoon, J. (2016) · Journal of Tissue Engineering and Regenerative Medicine · doi:10.1002/term.2240 · Cited by 11
Staubus, A., Alfadhli, A., Barklis, R. L., & Barklis, E. (2019) · Virology · doi:10.1016/j.virol.2019.09.008 · Cited by 10
Synthesis of a Giant 222 Carbon Graphite Sheet
Simpson, C. D., Brand, J. D., Berresheim, A. J., Przybilla, L., Räder, H. J., & Müllen, K. (2002) · Chemistry - A European Journal · doi:10.1002/1521-3765(20020315)8:6 · Cited by 373
HENKEL, M. K., Gregory, P. O. T. T., Henkel, A. W., Juliano, L., Kam, C.-M., POWERS, J. C., & Franzusoff, A. (1999) · Biochemical Journal · doi:10.1042/0264-6021:3410445 · Cited by 11
Mohan, T., Verma, P., & Rao, D. N. (2013) · Immunobiology · doi:10.1016/j.imbio.2013.11.001 · Cited by 11
Changing the Protease Specificity for Activation of a Flavivirus, Tick-Borne Encephalitis Virus
Fischl, W., Elshuber, S., Schrauf, S., & Mandl, C. W. (2008) · Journal of Virology · doi:10.1128/jvi.00587-08 · Cited by 11
Two engineered eglin c mutants potently and selectively inhibiting kexin or furin
Liu, Z., Hao, F., & Chi, C. (2003) · FEBS Letters · doi:10.1016/s0014-5793(03)01393-0 · Cited by 11
Barbouche, R., Decroly, É., Kiény, M. P., & Fenouillet, E. (2000) · Virology · doi:10.1006/viro.2000.0368 · Cited by 11
Bourinbaiar, A. S., Lee‐Huang, S., Krasinski, K., & Borkowsky, W. (1994) · Biomedicine & Pharmacotherapy · doi:10.1016/0753-3322(94)90076-0 · Cited by 11
Prévost, J., Medjahed, H., Vézina, D., Chen, H.-C., Hahn, B. H., Smith, A. B., & Finzi, A. (2021) · Viruses · doi:10.3390/v13112236 · Cited by 11
Neuronal and Non-Neuronal GABA in COVID-19: Relevance for Psychiatry
Sfera, A., Thomas, K. G., Sasannia, S., Anton, J. J., Andronescu, C. V., Garcia, M., Sfera, D. O., Cummings, M. A., & Kozlakidis, Z. (2022) · Reports — Medical Cases Images and Videos · doi:10.3390/reports5020022 · Cited by 11
Purification of recombinant vaccinia virus-expressed monomeric HIV-1 gp120 to apparent homogeneity
Guo, W., Cleveland, B., Davenport, T. M., Lee, K. K., & Hu, S. L. (2013) · Protein Expression and Purification · doi:10.1016/j.pep.2013.04.009 · Cited by 10
Furin cleavage of the Moloney murine leukemia virus Env precursor reorganizes the spike structure
Sjöberg, M., Wu, S.-R., Löving, R., Rantalainen, K. I., Lindqvist, B., & Garoff, H. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1317972111 · Cited by 10
Nakaya, Y., & Miyazawa, T. (2014) · Journal of Virology · doi:10.1128/jvi.00288-14 · Cited by 10
Furin as proprotein convertase and its role in normal and pathological biological processes
Solovyeva, N. I., Gureeva, T. A., Timoshenko, O. S., Moskvitina, T. A., & Kugaevskaya, E. V. (2017) · Biochemistry (Moscow) Supplement Series B Biomedical Chemistry · doi:10.1134/s1990750817020081 · Cited by 10
Song, C., Micoli, K., Bauerová, H., Pichová, I., & Hunter, E. (2005) · Journal of Virology · doi:10.1128/jvi.79.18.11559-11568.2005 · Cited by 10
Maenz, C., Chang, S., Iwanski, A., & Brüns, M. (2007) · Journal of Virology · doi:10.1128/jvi.02290-06 · Cited by 10
Radsak, K., Kern, H., Reis, B., Reschke, M., Mockenhaupt, T., & Eickmann, M. (1995) · Infectious agents and pathogenesis · doi:10.1007/978-1-4899-1100-1_16 · Cited by 10
Essalmani, R., Jain, J., Susan‐Resiga, D., Andréo, U., Evagelidis, A., Derbali, R. M., Huynh, D. N., Dallaire, F., Laporte, M., Delpal, A., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.12.18.423106 · Cited by 11
Analysis of HIV-1 envelope cytoplasmic tail effects on viral replication
Alfadhli, A., Romanaggi, C., Barklis, R. L., & Barklis, E. (2023) · Virology · doi:10.1016/j.virol.2022.12.017 · Cited by 9
Metadata
- Authors
- Hallenberger, S., Bosch, V., Angliker, H., Shaw, E., Klenk, H.-D., & Garten, W.
- Affiliations
- Philipps University of Marburg (DE)
- German Cancer Research Center (DE)
- Friedrich Miescher Institute (CH)
- Venue
- Nature
- Published
- 1992-11-26
- Volume
- 360
- Issue
- 6402
- Pages
- 358-361
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2001675486
- Cited by
- 582
- References
- 23
- Citations by year
- 2026: 5 · 2025: 5 · 2024: 14 · 2023: 18 · 2022: 13 · 2021: 24 · 2020: 23 · 2019: 14 · 2018: 20 · 2017: 9 · 2016: 14 · 2015: 23 · 2014: 24 · 2013: 17 · 2012: 27
- FWCI
- 10.83
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Protease and Inhibitor Mechanisms
- Health Sciences › Medicine › Infectious Diseases › HIV/AIDS drug development and treatment
- Keywords
- furin, HIV-1 envelope glycoprotein, gp160, proteolytic cleavage, furin inhibitors, viral fusion, infectious virus particles, endopeptidase
- MeSH terms
- Amino Acid Chloromethyl Ketones, Amino Acid Sequence, HeLa Cells, Humans, Molecular Sequence Data, Protein Precursors, Substrate Specificity, Subtilisins, Virus Replication, CD4-Positive T-Lymphocytes, HIV-1, Gene Products, env, Gene Expression, Consensus Sequence, HIV Envelope Protein gp160, Furin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review